Drug Reference

Teprotumumab

Monoclonal antibodies

← All medicines · Monoclonal antibodies

Fact box

Therapeutic class
Monoclonal antibodies
Action class
Insulin-like Growth Factor-1 Receptor Inhibitor
Mechanism
Insulin-like Growth Factor-1 Receptor Inhibitors
Habit forming
No

Brand names

Tepezza

Available as

500 MG · Injection

No structured FDA label was available. Use the authoritative links below.

Current FDA labels (DailyMed)

2 marketed products on record (RxNorm)

Authoritative sources

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.